There is significant interest inACUR by institutional investors. The 5.01% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Pharmaceuticals: Generic industry. Additionally, during the quarter ended December 2012, these large investors purchased a net $231.5 thousand shares.
| Other institutional | 2.62% |
| Mutual fund holders | 2.40% |
| Individual stakeholders | 132.17% |